WuXi AppTec, the Shanghai-based biotech giant, has sold its South Philly-based WuXi Advanced Therapies contract manufacturing unit to New York-based Altaris LLC, easing worries that federal limits ...

W uXi AppTec (OTCPK:WUXIF) and WuXi Biologics (OTCPK:WXIBF), two affiliated China-based drugmakers targeted in recent national security legislation, are seeking to sell some of their assets in the ...

Pharmaceutical company WuXi AppTec’s former Mendota Heights location is expected to close and 124 of its employees to be laid off following the company’s acquisition by North American Science ...

In response to the news that the US will soon announce significant import tariffs on pharmaceuticals, Edward Hu, Vice Chairman and Global Chief Investment Officer of WUXI APPTEC (02359.HK), said ...

A US congressional commission has urged lawmakers to take action to counter China’s “frightening” ascent in biotechnology, flagging Chinese firms including WuXi AppTec and BioMap ...

These successful results further reinforce WuXi AppTec's dedication to providing high-quality R&D and manufacturing solutions that support our customers worldwide in accelerating new drug ...